172 related articles for article (PubMed ID: 21387318)
1. Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release.
Vialpando M; Aerts A; Persoons J; Martens J; Van Den Mooter G
J Pharm Sci; 2011 Aug; 100(8):3411-3420. PubMed ID: 21387318
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen.
Vialpando M; Backhuijs F; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2012 May; 81(1):190-8. PubMed ID: 22306694
[TBL] [Abstract][Full Text] [Related]
3. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
[TBL] [Abstract][Full Text] [Related]
5. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
6. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
Quan GL; Chen B; Wang ZH; Wu H; Huang XT; Wu LN; Wu CB
Yao Xue Xue Bao; 2012 Feb; 47(2):239-43. PubMed ID: 22512038
[TBL] [Abstract][Full Text] [Related]
7. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
[TBL] [Abstract][Full Text] [Related]
8. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.
Mellaerts R; Mols R; Jammaer JA; Aerts CA; Annaert P; Van Humbeeck J; Van den Mooter G; Augustijns P; Martens JA
Eur J Pharm Biopharm; 2008 May; 69(1):223-30. PubMed ID: 18164930
[TBL] [Abstract][Full Text] [Related]
9. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
10. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
11. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
[TBL] [Abstract][Full Text] [Related]
12. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
13. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
14. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
Maleki A; Hamidi M
Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
[TBL] [Abstract][Full Text] [Related]
15. Agglomeration of mesoporous silica by melt and steam granulation. Part I: a comparison between disordered and ordered mesoporous silica.
Vialpando M; Albertini B; Passerini N; Bergers D; Rombaut P; Martens JA; Van Den Mooter G
J Pharm Sci; 2013 Nov; 102(11):3966-77. PubMed ID: 23946143
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property.
Zhang Y; Jiang T; Zhang Q; Wang S
Eur J Pharm Biopharm; 2010 Sep; 76(1):17-23. PubMed ID: 20685333
[TBL] [Abstract][Full Text] [Related]
17. Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs.
Vialpando M; Martens JA; Van den Mooter G
Ther Deliv; 2011 Aug; 2(8):1079-91. PubMed ID: 22833866
[TBL] [Abstract][Full Text] [Related]
18. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
[TBL] [Abstract][Full Text] [Related]
19. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
Pattnaik S; Pathak K
Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
